French Paper and Forestry Products Stock News

With no single headline event driving attention, Danone (ENXTPA:BN) is on investors’ radars after recent price moves and its current valuation metrics. This is prompting a closer look at the food and beverage group. See our latest analysis for Danone. Recent moves have been mixed, with a 1 day share price return of a 0.38% decline and a 7 day share price return of 1.05%, set against a 30 day share price return of a 4.96% decline. The 3 year total shareholder return of 29.25% suggests longer...

Market forces rained on the parade of Prodways Group SA ( EPA:ALPWG ) shareholders today, when the analysts downgraded...

The stock was sluggish on the back of 74Software's ( EPA:74SW ) recent earnings report. Along with the solid headline...

Eutelsat Communications is in talks with India's space agency ISRO about using its rockets for future satellite launches. The discussions focus on expanding launch options and deepening access to the Indian market. The potential partnership comes as India’s space sector continues to open up to commercial activity. Eutelsat Communications (ENXTPA:ETL) is exploring these talks while its shares trade around €2.045. The stock has seen a 14.5% gain year to date, but remains down 34.0% over 1...

Kekst CNC, a Publicis Groupe subsidiary, has appointed Lyndsey Estin as Co-CEO to lead U.S. operations. The move highlights Publicis Groupe’s focus on advanced communications capabilities in areas such as AI and cybersecurity. For investors tracking ENXTPA:PUB, this shift at Kekst CNC sits squarely in the core of Publicis Groupe’s communications and advisory activities. Kekst CNC is a global communications arm, and its work spans crisis counsel and complex corporate issues that many large...

ABIVAX Société Anonyme (ENXTPA:ABVX) is in focus after full year 2025 earnings showed revenue of €4.57 million and a net loss of €336.1 million, alongside fresh trial, leadership, financing, and index inclusion updates. See our latest analysis for ABIVAX Société Anonyme. The recent earnings release, positive Phase 3 safety update, leadership hires, ESOP related shelf registration, and FTSE All World Index inclusion come against a backdrop of a 1 year total shareholder return above 10x. At the...

Eurazeo (ENXTPA:RF) has been removed from the FTSE All-World Index. The change affects the stock’s presence in a major global equity benchmark tracked by index funds and ETFs. This type of index action can influence trading activity and how institutional investors view the company. Eurazeo is a listed investment company with exposure to private equity style assets, which means its share often sits on the radar of global fund managers. Being dropped from a widely followed index such as the...

Investors were underwhelmed by the solid earnings posted by SergeFerrari Group SA ( EPA:SEFER ) recently. We have done...

The market for Capgemini SE's ( EPA:CAP ) shares didn't move much after it posted weak earnings recently. We think that...

One of the biggest stories of last week was how STIF Société anonyme ( EPA:ALSTI ) shares plunged 26% in the week since...

As the European markets navigate through uncertainties spurred by geopolitical tensions and energy price fluctuations, investor sentiment remains cautious yet discerning. In such a climate, growth companies with high insider ownership often stand out as potentially resilient investments due to the alignment of interests between insiders and shareholders, which can be particularly advantageous during periods of economic volatility.

Today is shaping up negative for 2CRSI S.A. ( EPA:AL2SI ) shareholders, with the analysts delivering a substantial...

Ipsen (ENXTPA:IPN) has come into focus after presenting fresh preclinical data at the AACR congress for two first in class oncology candidates, IPN01203 and IPN60300, targeting difficult solid tumor indications. See our latest analysis for Ipsen. The latest oncology data and recent conference activity come at a time when Ipsen’s share price has reached €157.7, with recent momentum reflected in a 90 day share price return of 32.97% and a 1 year total shareholder return of 48.68%. This...

Investors in Innate Pharma S.A. ( EPA:IPH ) had a good week, as its shares rose 2.4% to close at €1.10 following the...

It's been a pretty great week for Netgem SA ( EPA:ALNTG ) shareholders, with its shares surging 11% to €0.76 in the...

Wondering whether EssilorLuxottica Société anonyme is starting to look attractively priced, or if the recent share price leaves little margin for error. The stock last closed at €194.80, with returns of 0.0% over 7 days, a 17.8% decline over 30 days, a 26.6% decline year to date, and a 25.8% decline over 1 year, set against gains of 23.8% over 3 years and 52.1% over 5 years. Recent moves in the share price sit against a backdrop of ongoing interest in the business and its role in the global...

How Accor’s Recent Share Performance Frames Today’s Setup Accor (ENXTPA:AC) has seen its share price fall about 17% over the past month and about 15% over the past 3 months, putting the hotel group’s current valuation and fundamentals back in focus for investors. See our latest analysis for Accor. That recent 17% 1 month share price decline sits against a 1 year total shareholder return of about a 3% decline and a 3 year total shareholder return of about 48%. This suggests shorter term...

DBV Technologies (ENXTPA:DBV) has put fresh numbers on the table for FY 2025, with third quarter revenue of US$2.8 million and a basic EPS loss of US$0.24 alongside a net income loss of US$33.2 million. Together, these figures provide a clear snapshot of where the business stands today. Over recent quarters, the company has reported revenue of US$0.5 million in Q4 2024, US$0.8 million in Q1 2025, US$1.5 million in Q2 2025 and US$2.8 million in Q3 2025. Over the same period, quarterly EPS has...

Quadient (ENXTPA:QDT) has opened FY 2026 with first half revenue of €517 million and basic EPS of €0.60, setting the tone for how its transition phase is feeding through to the income statement. Over the recent reporting periods, the company has seen revenue move from €534 million in H1 2025 to €558.6 million in H2 2025, with EPS shifting from €0.74 to €1.20 over the same stretch, while trailing 12 month EPS for H1 2026 sits at €1.80. The latest print gives investors a fresh read on how...

In March 2026, Schneider Electric announced at NVIDIA GTC that, together with NVIDIA and AVEVA, it had introduced new AI data center reference designs, Omniverse-integrated digital twins, and early agentic AI alarm management capabilities to improve the way next-generation data centers are designed, simulated, and operated. The collaboration embeds AVEVA’s software and Schneider’s SimReady assets throughout NVIDIA’s Omniverse DSX ecosystem, aiming to make gigawatt-scale “AI factories” more...

Alstom (ENXTPA:ALO) has secured a €380 million contract to upgrade and extend maintenance for the Skyway automated people mover at Houston Intercontinental Airport. The company has also signed a long-term support and refurbishment agreement for ScotRail's Class 222 fleet. Both agreements add multi year visibility to Alstom's services activity across North America and the UK rail markets. Alstom focuses on rail and mobility solutions, including rolling stock, signaling and long term...

Arkema announced a 20% expansion of its Kynar PVDF manufacturing capacity at its Changshu site in China. The new capacity targets demand from electric vehicle batteries, energy storage and high tech applications across Asia Pacific. The news highlights Arkema's focus on advanced materials for the energy transition. For investors watching Arkema (ENXTPA:AKE), this move comes with the shares trading around €54.3 and showing mixed recent performance. The stock is up 3.7% year to date, but has...

bioMérieux S.A.'s ( EPA:BIM ) stock was strong despite it releasing a soft earnings report last week. Our analysis...

ABIVAX Société Anonyme (ENXTPA:ABVX) has reported FY 2025 third quarter revenue of €0.639 million and a basic EPS loss of €2.10, while trailing twelve month figures show revenue of €5.311 million and a basic EPS loss of €4.46. Over recent quarters, revenue has moved from €1.351 million in Q3 2024 to €0.97 million in Q1 2025 and €1.047 million in Q2 2025, with basic EPS losses of €0.87, €0.83 and €0.76 across those same periods, and a trailing net loss of €293.52 million anchoring the story...